GE HealthCare Technologies Inc.
GEHC
주식 순위
#771
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
주가
$69.86
마지막 동기화: 2026-10-20
시가총액
$31.56B
변동 (1일)
0.15%
변동 (1년)
-8.19%
국가
US
거래 GE HealthCare Technologies Inc. (GEHC)
카테고리
Healthcare
GE HealthCare Technologies Inc. (GEHC)의 수익
Jun 2026 기준 수익 TTM: $2.04B
GE HealthCare Technologies Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $2.04B입니다. 2024년에 회사는 $2.58B의 수익을 올렸으며 이는 2023년의 수익 $2.36B과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
GE HealthCare Technologies Inc.의 수익 기록 (2019 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $2.04B | -26.19% |
| 2025 | $2.77B | 7.25% |
| 2024 | $2.58B | 9.32% |
| 2023 | $2.36B | -6.01% |
| 2022 | $2.51B | -12.63% |
| 2021 | $2.88B | 6.09% |
| 2020 | $2.71B | 29.60% |
| 2019 | $2.09B | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $266.26M | -86.97% |
AU
|
|
| $295.53M | -85.53% |
US
|
|
| $-259.89M | -112.72% |
US
|
|
| $-74.89M | -103.67% |
US
|
|
| - | - |
US
|
